Difference between revisions of "Jimeno A, et al. Clin. Cancer Res. (2013) cited as Ref 625 in DOI: 10.1038/s41392-020-0110-5 (Q9888)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 19, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: Page(s) (P105): 2766-2774, #quickstatements; #temporary_batch_1590074839150) |
||
| (One intermediate revision by the same user not shown) | |||
| Property / title | |||
| + | Phase I study of the Hedgehog pathway inhibitor IPI-926 in adult patients with solid tumors (English) | ||
| Property / title: Phase I study of the Hedgehog pathway inhibitor IPI-926 in adult patients with solid tumors (English) / rank | |||
| + | Normal rank | ||
| Property / Page(s) | |||
| + | 2766-2774 | ||
| Property / Page(s): 2766-2774 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:47, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Jimeno A, et al. Clin. Cancer Res. (2013) cited as Ref 625 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Jimeno A
0 references
2013
0 references
Clin. Cancer Res.
0 references
19
0 references
Phase I study of the Hedgehog pathway inhibitor IPI-926 in adult patients with solid tumors (English)
0 references
2766-2774
0 references
